Innovative strategies minimize engraftment syndrome in multiple myeloma patients with novel induction therapy following autologous hematopoietic stem cell transplantation.

导出 LinkOut

翻译打印收藏纠错

第一作者： Gonzalo,Gutiérrez-García

第一单位： Bone Marrow Transplant Unit, Department of Hematology, Hospital Clínic of Barcelona, Barcelona, Spain. gonguti@clinic.cat.

作者： Gonzalo,Gutiérrez-García ^[1] ; Montserrat,Rovira ^[2] ; Laura,Magnano ^[3] ; Laura,Rosiñol ^[4] ; Alex,Bataller ^[5] ; María,Suárez-Lledó ^[6] ; María Teresa,Cibeira ^[5] ; Carlos Fernández,de Larrea ^[6] ; Marta,Garrote ^[7] ; Sofia,Jorge ^[4] ; Ana,Moreno ^[5] ; Luis Gerardo,Rodríguez-Lobato ^[6] ; Enric,Carreras ^[7] ; Maribel,Díaz-Ricart ^[4] ; Marta,Palomo ^[5] ; Carmen,Martínez ^[6] ; Alvaro,Urbano-Ispizua ^[4] ; Joan,Bladé ^[5] ; Francesc,Fernández-Avilés ^[6]

作者单位： Bone Marrow Transplant Unit, Department of Hematology, Hospital Clínic of Barcelona, Barcelona, Spain. gonguti@clinic.cat. ^[1] University of Barcelona, Barcelona, Spain. gonguti@clinic.cat. ^[2] Institut de Recerca Biomèdica August Pi i Sunyer, Barcelona, Spain. gonguti@clinic.cat. ^[3] Bone Marrow Transplant Unit, Department of Hematology, Hospital Clínic of Barcelona, Barcelona, Spain. ^[4] University of Barcelona, Barcelona, Spain. ^[5] Institut de Recerca Biomèdica August Pi i Sunyer, Barcelona, Spain. ^[6] Amyloidosis and Multiple Myeloma/AL Unit, Department of Hematology, Hospital Clínic of Barcelona, Barcelona, Spain. ^[7] Barcelona Endothelium Team (BET), Josep Carreras Leukemia Research Institute, Barcelona, Spain. ^[8] Hematopathology Unit, Centre de Diagnòstic Biomèdic (CDB), Hospital Clínic of Barcelona, Barcelona, Spain. ^[9]